Why Theravance Biopharma Inc Shares Tumbled % Today Theravance Biopharma announced a stock and debt offering that disappointed investors. Theravance. SCHEDULE 13G Amendment No. 1 THERAVANCE BIOPHARMA INC COMMON STOCK Cusip #GB Check the appropriate box to designate the rule pursuant to which this. Theravance Biopharma Inc ; Jun, Initiated, Morgan Stanley, Equal-Weight, $30 ; May, Initiated, Cowen, Outperform, $ Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory. After Hours: $ (%) ; Innoviva Inc. $ INVA % ; ANI Pharmaceuticals Inc Common Stock. $ ANIP % ; Omeros Corp. $ OMER %.
Stock price for similar companies or competitors ; Theravance Biopharma Logo · Collegium Pharmaceutical. COLL. $, %, USA ; Theravance Biopharma Logo. The stock symbol for Theravance Biopharma is "TBPH." What Is the Theravance Biopharma Market Cap? As of today, Theravance Biopharma market cap is. Theravance Biopharma Inc TBPH:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date01/04/24 · 52 Week Low Theravance Biopharma, Inc NASDAQ: TBPH is a biopharmaceutical company primarily focused on the discovery, development and commercialization of respiratory. Valuation: Theravance Biopharma, Inc. ; P/E ratio * · EV / Sales * · Yield *. The current price of TBPH is USD — it has increased by % in the past 24 hours. Watch Theravance Biopharma, Inc. stock price performance more closely on. Theravance Bio stock falls more than 20% after drug trial disappoints. Shares of Theravance Biopharma Inc. fell more than 20% in the extended session Monday. Theravance Biopharma Inc ; Previous Close: ; Open: ; Volume: 91, ; 3 Month Average Trading Volume: ; Shares Out (Mil): Theravance Biopharma Inc. ; 12 Month Change. % ; Day Range - ; 52 Wk Range - ; Volume, K ; Market Value, $M. What is Theravance Biopharma Inc(TBPH)'s stock price today? The current price of TBPH is $ The 52 week high of TBPH is $ and 52 week low is $
Theravance Biopharma, Inc.'s revenue estimate for is $M. The latest low revenue estimate is $M and the high revenue estimate is $M. Learn. Stock Quote. NASDAQ: TBPH. $ + (+%). Volume, 52 Week High:$ 52 Week Low:$ Sep 13, PM EDT. Data Provided by Refinitiv. Discover real-time Theravance Biopharma, Inc. Ordinary Shares (TBPH) stock prices, quotes, historical data, news, and Insights for informed trading and. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends. The average price target is $ with a high forecast of $ and a low forecast of $ The average price target represents a % change from the. Latest Theravance Biopharma News: View TBPH news and discuss market sentiment with the investor community on jangkrik.ru Key statistics. On Wednesday, Theravance Biopharma Inc (TBPH:NMQ) closed at , % above its week low of , set on Aug 09, Theravance Biopharma Inc. · REAL TIME AM EDT 09/04/24 · USD · % · Volume, Theravance Biopharma, Inc. (TBPH) ; Aug 7, , , , , ; Aug 6, , , , ,
Theravance Biopharma stock was originally listed at a price of $ in May 16, If you had invested in Theravance Biopharma stock at $, your return. 16 minutes ago. Stock analysis for Theravance Biopharma Inc (TBPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company. Get Theravance Biopharma Inc. (TBPH) share price today, stock analysis, stock rating, price valuation, performance, fundamentals, market cap, shareholding. Theravance Biopharma (TBPH) - Develops and treatment of patients with chronic obstructive pulmonary disease (COPD) ; Theravance Biopharma Sees Relative Strength.
Analyst is 'extremely bullish' on biopharma